{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:15:28Z","timestamp":1790018128798,"version":"4.0.1"},"reference-count":170,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2019,11,22]]},"abstract":"<jats:sec><jats:title\/><jats:p>A small, non-enveloped, obligatory parasite, Human papillomavirus (HPV) is known to be the cause of a range of malignancies. These entail benign infections like genital warts as well as malignant, life-threatening conditions such as cervical cancer. Since a very high mortality rate is associated with HPV caused cancers (cervical cancer is a 2nd leading cause of death caused due to cancer among women globally), there is an escalating need to understand and search for ways to combat such medical conditions. Under the same light, the given article provides an insight into the world of this versatile pathogen. Distinct aspects related to HPV have been discussed here. Emphasis has been laid upon the composition, function and assembly of capsid proteins (structural studies) and various genetic elements and their gene products (genomic studies). The essence of the mechanism behind the development of persistent infection and modes responsible for the transmission of the infectious particles has been briefly covered. Finally, the review outlines various infections and diseases caused by HPV with a major focus on their clinical and histological manifestations.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389201020666190802115722","type":"journal-article","created":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T11:38:57Z","timestamp":1564918737000},"page":"1260-1280","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Structure, Genome, Infection Cycle and Clinical Manifestations Associated with Human Papillomavirus"],"prefix":"10.2174","volume":"20","author":[{"given":"Srishti","family":"Vashisht","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, Government of NCT of Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshita","family":"Mishra","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan K.","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Wood Processing, Mendel University in Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ekielski","sequence":"additional","affiliation":[{"name":"Department of Production Management and Engineering, Warsaw University of Life Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushama","family":"Talegaonkar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, Government of NCT of Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.virol.2013.06.007","volume":"445","author":"Cubie H.A.","year":"2013","unstructured":"Cubie H.A.; Diseases associated with human papillomavirus infection. Virology 2013,445(1-2),21-34","journal-title":"Virology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/rmv.1822","volume":"25","author":"Doorbar J.","year":"2015","unstructured":"Doorbar J.; Egawa N.; Griffin H.; Kranjec C.; Murakami I.; Human papillomavirus molecular biology and disease association. Rev Med Virol 2015,25(Suppl. 1),2-23","journal-title":"Rev Med Virol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.2741\/1971","volume":"11","author":"Zheng Z-M.","year":"2006","unstructured":"Zheng Z-M.; Baker C.C.; Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 2006,11,2286-2302","journal-title":"Front Biosci"},{"key":"ref=4","first-page":"25","volume":"5","author":"Yanofsky V.R.","year":"2012","unstructured":"Yanofsky V.R.; Patel R.V.; Goldenberg G.; Genital warts: A comprehensive review. J Clin Aesthet Dermatol 2012,5(6),25-36","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/1940-6207.CAPR-11-0542","volume":"5","author":"Lowy D.R.","year":"2012","unstructured":"Lowy D.R.; Schiller J.T.; Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 2012,5(1),18-23","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"de Martel C.","year":"2017","unstructured":"de Martel C.; Plummer M.; Vignat J.; Franceschi S.; Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017,141(4),664-670","journal-title":"Int J Cancer"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"Torre L.A.","year":"2015","unstructured":"Torre L.A.; Bray F.; Siegel R.L.; Ferlay J.; Lortet-Tieulent J.; Jemal A.; Global cancer statistics, 2012. CA Cancer J Clin 2015,65(2),87-108","journal-title":"CA Cancer J Clin"},{"key":"ref=8","year":"2007","unstructured":"Human Papillomaviruses International Agency for Research on Cancer2007","journal-title":"Human Papillomaviruses"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2217\/fmb.10.107","volume":"5","author":"Graham S.V.","year":"2010","unstructured":"Graham S.V.; Human papillomavirus: Gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol 2010,5(10),1493-1506","journal-title":"Future Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","volume":"445","author":"Wang J.W.","year":"2013","unstructured":"Wang J.W.; Roden R.B.; L2, the minor capsid protein of papillomavirus. Virology 2013,445(1-2),175-186","journal-title":"Virology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.virol.2013.05.038","volume":"445","author":"Buck C.B.","year":"2013","unstructured":"Buck C.B.; Day P.M.; Trus B.L.; The papillomavirus major capsid protein L1. Virology 2013,445(1-2),169-174","journal-title":"Virology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1128\/JVI.00330-13","volume":"87","author":"Raff A.B.","year":"2013","unstructured":"Raff A.B.; Woodham A.W.; Raff L.M.; Skeate J.G.; Yan L.; Da Silva D.M.; Schelhaas M.; Kast W.M.; The evolving field of human papillomavirus receptor research: A review of binding and entry. J Virol 2013,87(11),6062-6072","journal-title":"J Virol"},{"key":"ref=13","first-page":"403","author":"Buck C.B.","year":"2012","unstructured":"Buck C.B.; Trus B.L.; The papillomavirus virion: a machine built to hide molecular Achilles\u2019 heels Viral Mol Mach 2012,403-422","journal-title":"The papillomavirus virion: a machine built to hide molecular Achilles\u2019 heels Viral Mol Mach"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1128\/JVI.02726-07","volume":"82","author":"Buck C.B.","year":"2008","unstructured":"Buck C.B.; Cheng N.; Thompson C.D.; Lowy D.R.; Steven A.C.; Schiller J.T.; Trus B.L.; Arrangement of L2 within the papillomavirus capsid. J Virol 2008,82(11),5190-5197","journal-title":"J Virol"},{"key":"ref=15","unstructured":""},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1128\/JVI.75.9.4332-4342.2001","volume":"75","author":"Okun M.M.","year":"2001","unstructured":"Okun M.M.; Day P.M.; Greenstone H.L.; Booy F.P.; Lowy D.R.; Schiller J.T.; Roden R.B.; L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation. J Virol 2001,75(9),4332-4342","journal-title":"J Virol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1128\/JVI.79.5.2839-2846.2005","volume":"79","author":"Buck C.B.","year":"2005","unstructured":"Buck C.B.; Thompson C.D.; Pang Y-Y.S.; Lowy D.R.; Schiller J.T.; Maturation of papillomavirus capsids. J Virol 2005,79(5),2839-2846","journal-title":"J Virol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1093\/emboj\/cdf494","volume":"21","author":"Modis Y.","year":"2002","unstructured":"Modis Y.; Trus B.L.; Harrison S.C.; Atomic model of the papillomavirus capsid. EMBO J 2002,21(18),4754-4762","journal-title":"EMBO J"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1097-2765(00)80449-9","volume":"5","author":"Chen X.S.","year":"2000","unstructured":"Chen X.S.; Garcea R.L.; Goldberg I.; Casini G.; Harrison S.C.; Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 2000,5(3),557-567","journal-title":"Mol Cell"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"39730","DOI":"10.1038\/srep39730","volume":"6","author":"Bissett S.L.","year":"2016","unstructured":"Bissett S.L.; Godi A.; Beddows S.; The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies. Sci Rep 2016,6,39730","journal-title":"Sci Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.4049\/jimmunol.0902145","volume":"183","author":"Fahey L.M.","year":"2009","unstructured":"Fahey L.M.; Raff A.B.; Da Silva D.M.; Kast W.M.; A major role for the minor capsid protein of human papillomavirus type 16 in immune escape. J Immunol 2009,183(10),6151-6156","journal-title":"J Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1743-422X-5-150","volume":"5","author":"Lowe J.","year":"2008","unstructured":"Lowe J.; Panda D.; Rose S.; Jensen T.; Hughes W.A.; Tso F.Y.; Angeletti P.C.; Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yield novel insights into L2 structure and interaction with L1. Virol J 2008,5,150","journal-title":"Virol J"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1128\/JVI.61.5.1655-1660.1987","volume":"61","author":"Mallon R.G.","year":"1987","unstructured":"Mallon R.G.; Wojciechowicz D.; Defendi V.; DNA-binding activity of papillomavirus proteins. J Virol 1987,61(5),1655-1660","journal-title":"J Virol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1128\/JVI.77.8.4818-4826.2003","volume":"77","author":"Finnen R.L.","year":"2003","unstructured":"Finnen R.L.; Erickson K.D.; Chen X.S.; Garcea R.L.; Interactions between papillomavirus L1 and L2 capsid proteins. J Virol 2003,77(8),4818-4826","journal-title":"J Virol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.virol.2011.11.029","volume":"423","author":"Borgogna C.","year":"2012","unstructured":"Borgogna C.; Zavattaro E.; De Andrea M.; Griffin H.M.; Dell\u2019Oste V.; Azzimonti B.; Landini M.M.; Peh W.L.; Pfister H.; Doorbar J.; Landolfo S.; Gariglio M.; Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia verruciformis patients and in experimental models. Virology 2012,423(2),195-204","journal-title":"Virology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1074\/jbc.M311681200","volume":"279","author":"Auster A.S.","year":"2004","unstructured":"Auster A.S.; Joshua-Tor L.; The DNA-binding domain of human papillomavirus type 18 E1. Crystal structure, dimerization, and DNA binding. J Biol Chem 2004,279(5),3733-3742","journal-title":"J Biol Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.virol.2013.07.020","volume":"445","author":"Bergvall M.","year":"2013","unstructured":"Bergvall M.; Melendy T.; Archambault J.; The E1 proteins. Virology 2013,445(1-2),35-56","journal-title":"Virology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1128\/JVI.01829-10","volume":"85","author":"Morin G.","year":"2011","unstructured":"Morin G.; Fradet-Turcotte A.; Di Lello P.; Bergeron-Labrecque F.; Omichinski J.G.; Archambault J.; A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication. J Virol 2011,85(11),5287-5300","journal-title":"J Virol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1023\/A:1015336817836","volume":"24","author":"Wilson V.G.","year":"2002","unstructured":"Wilson V.G.; West M.; Woytek K.; Rangasamy D.; Papillomavirus E1 proteins: form, function, and features. Virus Genes 2002,24(3),275-290","journal-title":"Virus Genes"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1093\/nar\/21.25.5817","volume":"21","author":"Hughes F.J.","year":"1993","unstructured":"Hughes F.J.; Romanos M.A.; E1 protein of human papillomavirus is a DNA helicase\/ATPase. Nucleic Acids Res 1993,21(25),5817-5823","journal-title":"Nucleic Acids Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nature04943","volume":"442","author":"Enemark E.J.","year":"2006","unstructured":"Enemark E.J.; Joshua-Tor L.; Mechanism of DNA translocation in a replicative hexameric helicase. Nature 2006,442(7100),270-275","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/j.1460-2075.1988.tb03138.x","volume":"7","author":"Giri I.","year":"1988","unstructured":"Giri I.; Yaniv M.; Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J 1988,7(9),2823-2829","journal-title":"EMBO J"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1074\/jbc.275.1.87","volume":"275","author":"Webster K.","year":"2000","unstructured":"Webster K.; Parish J.; Pandya M.; Stern P.L.; Clarke A.R.; Gaston K.; The Human Papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J Biol Chem 2000,275(1),87-94","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.virol.2013.06.006","volume":"445","author":"McBride A.A.","year":"2013","unstructured":"McBride A.A.; The papillomavirus E2 proteins. Virology 2013,445(1-2),57-79","journal-title":"Virology"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.virusres.2016.11.005","volume":"231","author":"Dreer M.","year":"2017","unstructured":"Dreer M.; van de Poel S.; Stubenrauch F.; Control of viral replication and transcription by the papillomavirus E8^E2 protein. Virus Res 2017,231,96-102","journal-title":"Virus Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1074\/jbc.275.5.3522","volume":"275","author":"Sanders C.M.","year":"2000","unstructured":"Sanders C.M.; Stenlund A.; Transcription factor-dependent loading of the E1 initiator reveals modular assembly of the papillomavirus origin melting complex. J Biol Chem 2000,275(5),3522-3534","journal-title":"J Biol Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1128\/JVI.06450-11","volume":"86","author":"Egawa N.","year":"2012","unstructured":"Egawa N.; Nakahara T.; Ohno S.; Narisawa-Saito M.; Yugawa T.; Fujita M.; Yamato K.; Natori Y.; Kiyono T.; The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome. J Virol 2012,86(6),3276-3283","journal-title":"J Virol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1128\/JVI.05606-11","volume":"86","author":"V\u00f5sa L.","year":"2012","unstructured":"V\u00f5sa L.; Sudakov A.; Remm M.; Ustav M.; Kurg R.; Identification and analysis of papillomavirus E2 protein binding sites in the human genome. J Virol 2012,86(1),348-357","journal-title":"J Virol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.virol.2013.07.008","volume":"445","author":"Doorbar J.","year":"2013","unstructured":"Doorbar J.; The E4 protein; structure, function and patterns of expression. Virology 2013,445(1-2),80-98","journal-title":"Virology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.1128\/JVI.00670-11","volume":"85","author":"Wang X.","year":"2011","unstructured":"Wang X.; Meyers C.; Wang H-K.; Chow L.T.; Zheng Z-M.; Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol 2011,85(16),8080-8092","journal-title":"J Virol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1476-4598-10-140","volume":"10","author":"Venuti A.","year":"2011","unstructured":"Venuti A.; Paolini F.; Nasir L.; Corteggio A.; Roperto S.; Campo M.S.; Borzacchiello G.; Papillomavirus E5: The smallest oncoprotein with many functions. Mol Cancer 2011,10,140","journal-title":"Mol Cancer"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2217\/fvl.14.99","volume":"10","author":"M\u00fcller M.","year":"2015","unstructured":"M\u00fcller M.; Prescott E.L.; Wasson C.W.; Macdonald A.; Human papillomavirus E5 oncoprotein: Function and potential target for antiviral therapeutics. Future Virol 2015,10,27-39","journal-title":"Future Virol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.virol.2013.05.006","volume":"445","author":"DiMaio D.","year":"2013","unstructured":"DiMaio D.; Petti L.M.; The E5 proteins. Virology 2013,445(1-2),99-114","journal-title":"Virology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e02305","DOI":"10.1128\/JVI.02305-16","volume":"91","author":"Campos-Le\u00f3n K.","year":"2017","unstructured":"Campos-Le\u00f3n K.; Wijendra K.; Siddiqa A.; Pentland I.; Feeney K.M.; Knapman A.; Davies R.; Androphy E.J.; Parish J.L.; Association of human papillomavirus 16 E2 with Rad50-interacting protein 1 enhances viral DNA replication. J Virol 2017,91(5),e02305-e02316","journal-title":"J Virol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13046-017-0541-1","volume":"36","author":"de Freitas A.C.","year":"2017","unstructured":"de Freitas A.C.; de Oliveira T.H.A.; Barros M.R.; Venuti A.; hrHPV E5 oncoprotein: immune evasion and related immunotherapies. J Exp Clin Cancer Res 2017,36(1),71","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.1158\/0008-5472.CAN-05-0083","volume":"65","author":"Genther Williams S.M.","year":"2005","unstructured":"Genther Williams S.M.; Disbrow G.L.; Schlegel R.; Lee D.; Threadgill D.W.; Lambert P.F.; Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res 2005,65(15),6534-6542","journal-title":"Cancer Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.virol.2008.11.017","volume":"384","author":"Howie H.L.","year":"2009","unstructured":"Howie H.L.; Katzenellenbogen R.A.; Galloway D.A.; Papillomavirus E6 proteins. Virology 2009,384(2),324-334","journal-title":"Virology"},{"key":"ref=48","first-page":"2231","author":"Lowy D.R.","year":"2001","unstructured":"Lowy D.R.; Howley P.M.; Papillomaviruses. Fields Virol. Lippincott 2001,2231-2264","journal-title":"Lippincott"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1021\/bi001837+","volume":"40","author":"Lipari F.","year":"2001","unstructured":"Lipari F.; McGibbon G.A.; Wardrop E.; Cordingley M.G.; Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry 2001,40(5),1196-1204","journal-title":"Biochemistry"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.onc.1201202","volume":"15","author":"Pim D.","year":"1997","unstructured":"Pim D.; Massimi P.; Banks L.; Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene 1997,15(3),257-264","journal-title":"Oncogene"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1128\/JVI.01924-06","volume":"81","author":"Filippova M.","year":"2007","unstructured":"Filippova M.; Johnson M.M.; Bautista M.; Filippov V.; Fodor N.; Tungteakkhun S.S.; Williams K.; Duerksen-Hughes P.J.; The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J Virol 2007,81(8),4116-4129","journal-title":"J Virol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrm2451","volume":"9","author":"Murray-Zmijewski F.","year":"2008","unstructured":"Murray-Zmijewski F.; Slee E.A.; Lu X.; A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 2008,9(9),702-712","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","volume":"12","author":"Ronco L.V.","year":"1998","unstructured":"Ronco L.V.; Karpova A.Y.; Vidal M.; Howley P.M.; Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 1998,12(13),2061-2072","journal-title":"Genes Dev"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.4049\/jimmunol.178.5.3186","volume":"178","author":"Hasan U.A.","year":"2007","unstructured":"Hasan U.A.; Bates E.; Takeshita F.; Biliato A.; Accardi R.; Bouvard V.; Mansour M.; Vincent I.; Gissmann L.; Iftner T.; Sideri M.; Stubenrauch F.; Tommasino M.; TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol 2007,178(5),3186-3197","journal-title":"J Immunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1006\/bbrc.1998.9066","volume":"249","author":"Kukimoto I.","year":"1998","unstructured":"Kukimoto I.; Aihara S.; Yoshiike K.; Kanda T.; Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein. Biochem Biophys Res Commun 1998,249(1),258-262","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","volume":"445","author":"Roman A.","year":"2013","unstructured":"Roman A.; Munger K.; The papillomavirus E7 proteins. Virology 2013,445(1-2),138-168","journal-title":"Virology"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.virol.2005.04.036","volume":"338","author":"McLaughlin-Drubin M.E.","year":"2005","unstructured":"McLaughlin-Drubin M.E.; Bromberg-White J.L.; Meyers C.; The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology 2005,338(1),61-68","journal-title":"Virology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"8852","DOI":"10.1128\/JVI.00664-11","volume":"85","author":"Bodily J.M.","year":"2011","unstructured":"Bodily J.M.; Mehta K.P.M.; Cruz L.; Meyers C.; Laimins L.A.; The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J Virol 2011,85(17),8852-8862","journal-title":"J Virol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1128\/JVI.00483-12","volume":"86","author":"Cornet I.","year":"2012","unstructured":"Cornet I.; Gheit T.; Franceschi S.; Vignat J.; Burk R.D.; Sylla B.S.; Tommasino M.; Clifford G.M.; Human papillomavirus type 16 genetic variants: Phylogeny and classification based on E6 and LCR. J Virol 2012,86(12),6855-6861","journal-title":"J Virol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JVI.73.3.1918-1930.1999","volume":"73","author":"St\u00fcnkel W.","year":"1999","unstructured":"St\u00fcnkel W.; Bernard H.U.; The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol 1999,73(3),1918-1930","journal-title":"J Virol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1099\/vir.0.80551-0","volume":"86","author":"Smola-Hess S.","year":"2005","unstructured":"Smola-Hess S.; Pahne J.; Mauch C.; Zigrino P.; Smola H.; Pfister H.J.; Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: Role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J Gen Virol 2005,86(Pt 5),1291-1296","journal-title":"J Gen Virol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/infdis\/jis430","volume":"206","author":"Sichero L.","year":"2012","unstructured":"Sichero L.; Sobrinho J.S.; Villa L.L.; Identification of novel cellular transcription factors that regulate early promoters of human papillomavirus types 18 and 16. J Infect Dis 2012,206(6),867-874","journal-title":"J Infect Dis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","volume":"401","author":"Bernard H-U.","year":"2010","unstructured":"Bernard H-U.; Burk R.D.; Chen Z.; van Doorslaer K.; zur Hausen H.; de Villiers E-M.; Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010,401(1),70-79","journal-title":"Virology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"de Villiers E-M.","year":"2004","unstructured":"de Villiers E-M.; Fauquet C.; Broker T.R.; Bernard H-U.; zur Hausen H.; Classification of papillomaviruses. Virology 2004,324(1),17-27","journal-title":"Virology"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.virol.2014.12.028","volume":"476","author":"Bzhalava D.","year":"2015","unstructured":"Bzhalava D.; Eklund C.; Dillner J.; International standardization and classification of human papillomavirus types. Virology 2015,476,341-344","journal-title":"Virology"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1038\/srep05807","volume":"4","author":"Bzhalava D.","year":"2014","unstructured":"Bzhalava D.; M\u00fchr L.S.A.; Lagheden C.; Ekstr\u00f6m J.; Forslund O.; Dillner J.; Hultin E.; Deep sequencing extends the diversity of human papillomaviruses in human skin. Sci Rep 2014,4,5807","journal-title":"Sci Rep"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2013.01.023","volume":"440","author":"Johansson H.","year":"2013","unstructured":"Johansson H.; Bzhalava D.; Ekstr\u00f6m J.; Hultin E.; Dillner J.; Forslund O.; Metagenomic sequencing of \u201cHPV-negative\u201d condylomas detects novel putative HPV types. Virology 2013,440(1),1-7","journal-title":"Virology"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"Burd E.M.","year":"2003","unstructured":"Burd E.M.; Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003,16(1),1-17","journal-title":"Clin Microbiol Rev"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"Mu\u00f1oz N.","year":"2003","unstructured":"Mu\u00f1oz N.; Bosch F.X.; de Sanjos\u00e9 S.; Herrero R.; Castellsagu\u00e9 X.; Shah K.V.; Snijders P.J.; Meijer C.J.; Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003,348(6),518-527","journal-title":"N Engl J Med"},{"key":"ref=70","first-page":"728","author":"Procop G.W.","year":"2014","unstructured":"Procop G.W.; Pritt B.S.; Human papillomavirus, polyomavirus and parvovirus infections. Pathol Infect Dis E-Book Vol Ser Found Diagn Pathol. Elsevier Saunders 2014,728","journal-title":"Elsevier Saunders"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.3390\/v6124856","volume":"6","author":"Richards K.F.","year":"2014","unstructured":"Richards K.F.; Mukherjee S.; Bienkowska-Haba M.; Pang J.; Sapp M.; Human papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor. Viruses 2014,6(12),4856-4879","journal-title":"Viruses"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1128\/JVI.00569-08","volume":"82","author":"Laniosz V.","year":"2008","unstructured":"Laniosz V.; Holthusen K.A.; Meneses P.I.; Bovine papillomavirus type 1: From clathrin to caveolin. J Virol 2008,82(13),6288-6298","journal-title":"J Virol"},{"key":"ref=73","first-page":"65","author":"Machado F.S.","year":"2012","unstructured":"Machado F.S.; Rodriguez N.E.; Adesse D.; Garzoni L.R.; Esper L.; Lisanti M.P.; Recent developments in the interactions between caveolin and pathogens Caveolins Caveolae In 2012,65-82","journal-title":"Recent developments in the interactions between caveolin and pathogens Caveolins Caveolae In"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"9922","DOI":"10.1128\/JVI.00988-07","volume":"81","author":"Smith J.L.","year":"2007","unstructured":"Smith J.L.; Campos S.K.; Ozbun M.A.; Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J Virol 2007,81(18),9922-9931","journal-title":"J Virol"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003313","volume":"3","author":"Spoden G.","year":"2008","unstructured":"Spoden G.; Freitag K.; Husmann M.; Boller K.; Sapp M.; Lambert C.; Florin L.; Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 2008,3(10)","journal-title":"PLoS One"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1743-422X-7-2","volume":"7","author":"Letian T.","year":"2010","unstructured":"Letian T.; Tianyu Z.; Cellular receptor binding and entry of human papillomavirus. Virol J 2010,7,2","journal-title":"Virol J"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","volume":"30","author":"Doorbar J.","year":"2012","unstructured":"Doorbar J.; Quint W.; Banks L.; Bravo I.G.; Stoler M.; Broker T.R.; Stanley M.A.; The biology and life-cycle of human papillomaviruses. Vaccine 2012,30(Suppl. 5),F55-F70","journal-title":"Vaccine"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ygyno.2010.04.004","volume":"118","author":"Schiller J.T.","year":"2010","unstructured":"Schiller J.T.; Day P.M.; Kines R.C.; Current understanding of the mechanism of HPV infection. Gynecol Oncol 2010,118(1)(Suppl.),S12-S17","journal-title":"Gynecol Oncol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13027-016-0107-4","volume":"11","author":"Senapati R.","year":"2016","unstructured":"Senapati R.; Senapati N.N.; Dwibedi B.; Molecular mechanisms of HPV mediated neoplastic progression. Infect Agent Cancer 2016,11,59","journal-title":"Infect Agent Cancer"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1743-422X-7-11","volume":"7","author":"Horvath C.A.","year":"2010","unstructured":"Horvath C.A.; Boulet G.A.; Renoux V.M.; Delvenne P.O.; Bogers J-P.J.; Mechanisms of cell entry by human papillomaviruses: an overview. Virol J 2010,7,11","journal-title":"Virol J"},{"key":"ref=81","first-page":"2","volume":"1","author":"Braaten K.P.","year":"2008","unstructured":"Braaten K.P.; Laufer M.R.; Human Papillomavirus (HPV), HPV-related disease, and the HPV vaccine. Rev Obstet Gynecol 2008,1(1),2-10","journal-title":"Rev Obstet Gynecol"},{"key":"ref=82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066368","volume":"8","author":"Lee S.M.","year":"2013","unstructured":"Lee S.M.; Park J.S.; Norwitz E.R.; Koo J.N.; Oh I.H.; Park J.W.; Kim S.M.; Kim Y.H.; Park C.W.; Song Y.S.; Risk of vertical transmission of human papillomavirus throughout pregnancy: A prospective study. PLoS One 2013,8(6)","journal-title":"PLoS One"},{"key":"ref=83","first-page":"453","volume":"7","author":"Handisurya A.","year":"2009","unstructured":"Handisurya A.; Schellenbacher C.; Kirnbauer R.; Diseases caused by human papillomaviruses (HPV). J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 2009,7,453-466","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1590\/S0365-05962011000200014","volume":"86","author":"Leto Md.","year":"2011","unstructured":"Leto Md.; Santos J\u00fanior G.F.; Porro A.M.; Tomimori J.; Human papillomavirus infection: Etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol 2011,86(2),306-317","journal-title":"An Bras Dermatol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"136","DOI":"10.17305\/bjbms.2014.3.29","volume":"14","author":"Ural A.","year":"2014","unstructured":"Ural A.; Arslan S.; Ers\u00f6z \u015e.; De\u011fer B.; Verruca vulgaris of the tongue: A case report with a literature review. Bosn J Basic Med Sci 2014,14(3),136-138","journal-title":"Bosn J Basic Med Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jcv.2013.02.021","volume":"57","author":"Bruggink S.C.","year":"2013","unstructured":"Bruggink S.C.; Gussekloo J.; de Koning M.N.C.; Feltkamp M.C.W.; Bavinck J.N.B.; Quint W.G.V.; Assendelft W.J.; Eekhof J.A.; HPV type in plantar warts influences natural course and treatment response: Secondary analysis of a randomised controlled trial. J Clin Virol 2013,57(3),227-232","journal-title":"J Clin Virol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1046\/j.1365-2133.1998.02112.x","volume":"138","author":"Egawa K.","year":"1998","unstructured":"Egawa K.; Honda Y.; Inaba Y.; Ono T.; Pigmented viral warts: A clinical and histopathological study including human papillomavirus typing. Br J Dermatol 1998,138(3),381-389","journal-title":"Br J Dermatol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/0974-2077.41154","volume":"1","author":"Patidar S.","year":"2008","unstructured":"Patidar S.; Combination treatment of periungual warts. J Cutan Aesthet Surg 2008,1(1),23-24","journal-title":"J Cutan Aesthet Surg"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jaad.2010.02.057","volume":"64","author":"Riddel C.","year":"2011","unstructured":"Riddel C.; Rashid R.; Thomas V.; Ungual and periungual human papillomavirus-associated squamous cell carcinoma: A review. J Am Acad Dermatol 2011,64(6),1147-1153","journal-title":"J Am Acad Dermatol"},{"key":"ref=90","first-page":"33","volume":"58","author":"Neagu T.P.","year":"2017","unstructured":"Neagu T.P.; \u0162igli\u015f M.; Botezatu D.; Enache V.; Cobilinschi C.O.; V\u00e2lcea-Precup M.S.; Grin\u0162escu, I.M. Clinical, histological and therapeutic features of Bowen\u2019s disease. Rom J Morphol Embryol 2017,58(1),33-40","journal-title":"Rom J Morphol Embryol"},{"key":"ref=91","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/421460","volume":"2015","author":"Morley G.L.","year":"2015","unstructured":"Morley G.L.; Matthews J.H.; Verpetinske I.; Thom G.A.; A Comparative study examining the management of Bowen\u2019s disease in the United Kingdom and Australia. Dermatol Res Pract 2015,2015","journal-title":"Dermatol Res Pract"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/229255031001800105","volume":"18","author":"Emsen I.M.","year":"2010","unstructured":"Emsen I.M.; Kabalar M.E.; Epidermodysplasia verruciformis: An early and unusual presentation. Can J Plast Surg 2010,18(1),21-24","journal-title":"Can J Plast Surg"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1590\/S0365-05962011000700014","volume":"86","author":"S\u00e1 N.B.","year":"2011","unstructured":"S\u00e1 N.B.; Guerini M.B.; Barbato M.T.; Di Giunta G.; Nunes D.H.; Epidermodysplasia verruciformis: Clinical presentation with varied forms of lesions. An Bras Dermatol 2011,86(4)(Suppl. 1),S57-S60","journal-title":"An Bras Dermatol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-2004-836942","volume":"17","author":"Chang G.J.","year":"2004","unstructured":"Chang G.J.; Welton M.L.; Human papillomavirus, condylomata acuminata, and anal neoplasia. Clin Colon Rectal Surg 2004,17(4),221-230","journal-title":"Clin Colon Rectal Surg"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3315\/jdcr.2008.1019","volume":"2","author":"Martin J.M.","year":"2008","unstructured":"Martin J.M.; Molina I.; Monteagudo C.; Marti N.; Lopez V.; Jorda E.; Buschke-Lowenstein tumor. J Dermatol Case Rep 2008,2(4),60-62","journal-title":"J Dermatol Case Rep"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijscr.2014.01.023","volume":"5","author":"Agarwal S.","year":"2014","unstructured":"Agarwal S.; Nirwal G.K.; Singh H.; Buschke-Lowenstein tumour of glans penis. Int J Surg Case Rep 2014,5(5),215-218","journal-title":"Int J Surg Case Rep"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1590\/abd1806-4841.20164595","volume":"91","author":"Ant\u00f4nio J.R.","year":"2016","unstructured":"Ant\u00f4nio J.R.; Ant\u00f4nio C.R.; Tr\u00eddico L.A.; Alves F.T.; Rollemberg I.; Erythroplasia of Queyrat treated with topical 5-fluorouracil. An Bras Dermatol 2016,91(5)(Suppl. 1),42-44","journal-title":"An Bras Dermatol"},{"key":"ref=98","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/480573","volume":"2014","author":"L\u00e9onard B.","year":"2014","unstructured":"L\u00e9onard B.; Kridelka F.; Delbecque K.; Goffin F.; Demoulin S.; Doyen J.; Delvenne P.; A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma. BioMed Res Int 2014,2014","journal-title":"BioMed Res Int"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ijsu.2013.04.011","volume":"11","author":"Orchard M.","year":"2013","unstructured":"Orchard M.; Roman A.; Parvaiz A.C.; Anal intraepithelial neoplasia--is treatment better than observation? Int J Surg 2013,11(6),438-441","journal-title":"Int J Surg"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/1471-0528.12223","volume":"120","author":"Ratnavelu N.","year":"2013","unstructured":"Ratnavelu N.; Patel A.; Fisher A.D.; Galaal K.; Cross P.; Naik R.; High-grade vaginal intraepithelial neoplasia: Can we be selective about who we treat? BJOG 2013,120(7),887-893","journal-title":"BJOG"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.semdp.2011.08.009","volume":"29","author":"Velazquez E.F.","year":"2012","unstructured":"Velazquez E.F.; Chaux A.; Cubilla A.L.; Histologic classification of penile intraepithelial neoplasia. Semin Diagn Pathol 2012,29(2),96-102","journal-title":"Semin Diagn Pathol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/01.XHA.0000423421.22785.86","volume":"3","author":"Zreik A.","year":"2013","unstructured":"Zreik A.; Ismail M.; Nigam R.; Penile intraepithelial neoplasia: Management and outcomes. Hum Androl 2013,3,6-9","journal-title":"Hum Androl"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/1097-0142(196611)19:11<1635:AID-CNCR2820191130>3.0.CO;2-1","volume":"19","author":"Richart R.M.","year":"1966","unstructured":"Richart R.M.; Influence of diagnostic and therapeutic procedures on the distribution of cervical intraepithelial neoplasia. Cancer 1966,19(11),1635-1638","journal-title":"Cancer"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.35.1.1","volume":"35","author":"Buckley C.H.","year":"1982","unstructured":"Buckley C.H.; Butler E.B.; Fox H.; Cervical intraepithelial neoplasia. J Clin Pathol 1982,35(1),1-13","journal-title":"J Clin Pathol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/TCRM.S81825","volume":"11","author":"Carifi M.","year":"2015","unstructured":"Carifi M.; Napolitano D.; Morandi M.; Dall\u2019Olio D.; Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag 2015,11,731-738","journal-title":"Ther Clin Risk Manag"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000327094","volume":"4","author":"Katsenos S.","year":"2011","unstructured":"Katsenos S.; Becker H.D.; Recurrent respiratory papillomatosis: A rare chronic disease, difficult to treat, with potential to lung cancer transformation: apropos of two cases and a brief literature review. Case Rep Oncol 2011,4(1),162-171","journal-title":"Case Rep Oncol"},{"key":"ref=107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099114","volume":"9","author":"Omland T.","year":"2014","unstructured":"Omland T.; Lie K.A.; Akre H.; Sandlie L.E.; Jebsen P.; Sandvik L.; Nymoen D.A.; Bzhalava D.; Dillner J.; Br\u00f8ndbo K.; Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia. PLoS One 2014,9(6)","journal-title":"PLoS One"},{"key":"ref=108","year":"2015","unstructured":"Recurrent Respiratory Papillomatosis or Laryngeal Papillomatosis available at2015"},{"key":"ref=109","first-page":"815","volume":"11","author":"Al Juboori A.M.","year":"2015","unstructured":"Al Juboori A.M.; Afzal Z.; Ahmed N.; Esophageal squamous cell papilloma: A not-so-rare cause of dysphagia. Gastroenterol Hepatol (N Y) 2015,11(12),815-816","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref=110","first-page":"31","volume":"4","author":"D Kalogeropoulos C.","year":"2015","unstructured":"D Kalogeropoulos C.; M Moschos M.; Advances in diagnosis and treatment of HPV ocular surface infections. Med Hypothesis Discov Innov Ophthalmol 2015,4(2),31-35","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1443-1661.2004.00411.x","volume":"16","author":"Oguma J.","unstructured":"Oguma J.; Ozawa S.; Kitagawa Y.; Saikawa Y.; Oyama T.; Kitajima M.; Squamous: Clinicopathological study of 24 cases. Dig Endosc ,16,285-288","journal-title":"Dig Endosc"},{"key":"ref=112","volume":"2014","author":"Sasi W.","year":"2014","unstructured":"Sasi W.; Banerjee D.; Mokbel K.; Sharma A.K.; Bilateral florid papillomatosis of the nipple: An unusual indicator for metachronous breast cancer development-a case report. Case Rep Oncol Med 2014,2014","journal-title":"Case Rep Oncol Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1590\/S0103-64402006000100018","volume":"17","author":"Borborema-Santos C.M.","year":"2006","unstructured":"Borborema-Santos C.M.; Castro M.M.; Santos P.J.; Talhari S.; Astolfi-Filho S.; Oral focal epithelial hyperplasia: Report of five cases. Braz Dent J 2006,17(1),79-82","journal-title":"Braz Dent J"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"346","DOI":"10.14740\/jocmr2466w","volume":"8","author":"de Castro L.A.","year":"2016","unstructured":"de Castro L.A.; de Castro J.G.L.; da Cruz A.D.L.; Barbosa B.H de S.; de Spindula-Filho J.V.; Costa M.B.; Focal epithelial hyperplasia (Heck\u2019s Disease) in a 57-Year-Old Brazilian Patient: A Case Report and Literature Review. J Clin Med Res 2016,8(4),346-350","journal-title":"J Clin Med Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12663-011-0184-2","volume":"10","author":"Ozden B.","year":"2011","unstructured":"Ozden B.; Gunduz K.; Gunhan O.; Ozden F.O.; A Case Report of Focal Epithelial Hyperplasia (Heck\u2019s disease) with PCR Detection of human papillomavirus. J Maxillofac Oral Surg 2011,10(4),357-360","journal-title":"J Maxillofac Oral Surg"},{"key":"ref=116","first-page":"138","volume":"6","author":"Sarabadani J.","year":"2017","unstructured":"Sarabadani J.; Heydari S.; Mashreghi A.; Poornazari N.; A Case report of multifocal epithelial hyperplasia (Heck\u2019s Disease) treated with CO laser. J Dent Mater Tech 2017,6,138-141","journal-title":"J Dent Mater Tech"},{"key":"ref=117","author":"Cawson R.A.","year":"2012","unstructured":"Cawson R.A.; Odell E.W.; Cawson\u2019s essentials of oral pathology and oral medicine. Churchill Livingstone 2012","journal-title":"Churchill Livingstone"},{"key":"ref=118","doi-asserted-by":"publisher","DOI":"10.4137\/CMO.S12017","author":"Eze J.N.","year":"2013","unstructured":"Eze J.N.; Emeka-Irem E.N.; Edegbe F.O.; A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in southeast Nigeria. Clin Med Insights Oncol 2013","journal-title":"Clin Med Insights Oncol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12905-016-0306-6","volume":"16","author":"Finocchario-Kessler S.","year":"2016","unstructured":"Finocchario-Kessler S.; Wexler C.; Maloba M.; Mabachi N.; Ndikum-Moffor F.; Bukusi E.; Cervical cancer prevention and treatment research in Africa: A systematic review from a public health perspective. BMC Womens Health 2016,16,29","journal-title":"BMC Womens Health"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/bmj.39337.615197.80","volume":"335","author":"Petignat P.","year":"2007","unstructured":"Petignat P.; Roy M.; Diagnosis and management of cervical cancer. BMJ 2007,335(7623),765-768","journal-title":"BMJ"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1158\/1055-9965.EPI-12-1406","volume":"22","author":"Schiffman M.","year":"2013","unstructured":"Schiffman M.; Wentzensen N.; Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev 2013,22(4),553-560","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/IJWH.S68979","volume":"7","author":"Alkatout I.","year":"2015","unstructured":"Alkatout I.; Schubert M.; Garbrecht N.; Weigel M.T.; Jonat W.; Mundhenke C.; G\u00fcnther V.; Vulvar cancer: Epidemiology, clinical presentation, and management options. Int J Womens Health 2015,7,305-313","journal-title":"Int J Womens Health"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jaad.2013.11.027","volume":"70","author":"Sagdeo A.","year":"2014","unstructured":"Sagdeo A.; Gormley R.H.; Abuabara K.; Tyring S.K.; Rady P.; Elder D.E.; Kovarik C.L.; The diagnostic challenge of vulvar squamous cell carcinoma: Clinical manifestations and unusual human papillomavirus types. J Am Acad Dermatol 2014,70(3),586-588","journal-title":"J Am Acad Dermatol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/AOG.0000000000000171","volume":"123","author":"Sinno A.K.","year":"2014","unstructured":"Sinno A.K.; Saraiya M.; Thompson T.D.; Hernandez B.Y.; Goodman M.T.; Steinau M.; Lynch C.F.; Cozen W.; Saber M.S.; Peters E.S.; Wilkinson E.J.; Copeland G.; Hopenhayn C.; Watson M.; Lyu C.; Unger E.R.; Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population. Obstet Gynecol 2014,123(4),817-821","journal-title":"Obstet Gynecol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1758834012471699","volume":"5","author":"Woelber L.","year":"2013","unstructured":"Woelber L.; Trillsch F.; Kock L.; Grimm D.; Petersen C.; Choschzick M.; Jaenicke F.; Mahner S.; Management of patients with vulvar cancer: A perspective review according to tumour stage. Ther Adv Med Oncol 2013,5(3),183-192","journal-title":"Ther Adv Med Oncol"},{"key":"ref=126","year":"2016","unstructured":"2016"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/2229-516X.179027","volume":"6","author":"Bansal A.","year":"2016","unstructured":"Bansal A.; Singh M.P.; Rai B.; Human papillomavirus-associated cancers: A growing global problem. Int J Appl Basic Med Res 2016,6(2),84-89","journal-title":"Int J Appl Basic Med Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4137\/CMO.S13241","volume":"8","author":"Gami B.","year":"2014","unstructured":"Gami B.; Kubba F.; Ziprin P.; Human papilloma virus and squamous cell carcinoma of the anus. Clin Med Insights Oncol 2014,8,113-119","journal-title":"Clin Med Insights Oncol"},{"key":"ref=129","first-page":"293","volume":"12","author":"Pereira A.C.C.","year":"2008","unstructured":"Pereira A.C.C.; Lacerda H.R.; Barros R.C.; Diagnostic methods for prevention of anal cancer and characteristics of anal lesions caused by HPV in men with HIV\/AIDS. Braz J Infect Dis 2008,12(4),293-299","journal-title":"Braz J Infect Dis"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/1055-9965.EPI-15-0044","volume":"24","author":"Shiels M.S.","year":"2015","unstructured":"Shiels M.S.; Kreimer A.R.; Coghill A.E.; Darragh T.M.; Devesa S.S.; Anal cancer incidence in the United States, 1977-2011: Distinct patterns by histology and behavior. Cancer Epidemiol Prev Biomark 2015,24(10),1548-1556","journal-title":"Cancer Epidemiol Prev Biomark"},{"key":"ref=131","unstructured":""},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","volume":"11","author":"Clark P.E.","year":"2013","unstructured":"Clark P.E.; Spiess P.E.; Agarwal N.; Biagioli M.C.; Eisenberger M.A.; Greenberg R.E.; Herr H.W.; Inman B.A.; Kuban D.A.; Kuzel T.M.; Lele S.M.; Michalski J.; Pagliaro L.; Pal S.K.; Patterson A.; Plimack E.R.; Pohar K.S.; Porter M.P.; Richie J.P.; Sexton W.J.; Shipley W.U.; Small E.J.; Trump D.L.; Wile G.; Wilson T.G.; Dwyer M.; Ho M.; Penile cancer. J Natl Compr Canc Netw 2013,11(5),594-615","journal-title":"J Natl Compr Canc Netw"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s10552-011-9785-9","volume":"22","author":"Larke N.L.","year":"2011","unstructured":"Larke N.L.; Thomas S.L.; dos Santos Silva I.; Weiss H.A.; Male circumcision and penile cancer: A systematic review and meta-analysis. Cancer Causes Control 2011,22(8),1097-1110","journal-title":"Cancer Causes Control"},{"key":"ref=134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122557","volume":"10","author":"Lau Y.M.","year":"2015","unstructured":"Lau Y.M.; Cheung T.H.; Yeo W.; Mo F.; Yu M.Y.; Lee K.M.; Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment. PLoS One 2015,10(4)","journal-title":"PLoS One"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","volume":"65","author":"Viens L.J.","year":"2016","unstructured":"Viens L.J.; Henley S.J.; Watson M.; Markowitz L.E.; Thomas C.C.; Thompson T.D.; Razzaghi H.; Saraiya M.; Human papillomavirus-associated cancers - United States, 2008-2012. MMWR Morb Mortal Wkly Rep 2016,65(26),661-666","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=136","first-page":"77","volume":"33","author":"Boscolo-Rizzo P.","year":"2013","unstructured":"Boscolo-Rizzo P.; Del Mistro A.; Bussu F.; Lupato V.; Baboci L.; Almadori G.; New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital. Organo Uff Della Soc. Ital. Otorinolaringol. E Chir. Cerv-facc 2013,33,77-87","journal-title":"Cerv-facc"},{"key":"ref=137","first-page":"239","volume":"79","author":"Galbiatti A.L.S.","year":"2013","unstructured":"Galbiatti A.L.S.; Padovani-Junior J.A.; Man\u00edglia J.V.; Rodrigues C.D.S.; Pavarino \u00c9.C.; Goloni-Bertollo E.M.; Head and neck cancer: Causes, prevention and treatment. Rev Bras Otorrinolaringol, (Engl Ed) 2013,79(2),239-247","journal-title":"Rev Bras Otorrinolaringol, (Engl Ed)"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1750-9378-8-14","volume":"8","author":"Ndiaye C.","year":"2013","unstructured":"Ndiaye C.; Alemany L.; Diop Y.; Ndiaye N.; Di\u00e9m\u00e9 M-J.; Tous S.; Klaustermeier J.E.; Alejo M.; Castellsagu\u00e9 X.; Bosch F.X.; Trottier H.; Sanjos\u00e9 S.; The role of human papillomavirus in head and neck cancer in Senegal. Infect Agent Cancer 2013,8(1),14","journal-title":"Infect Agent Cancer"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.oraloncology.2014.02.012","volume":"50","author":"Nordfors C.","year":"2014","unstructured":"Nordfors C.; Vlastos A.; Du J.; \u00c4hrlund-Richter A.; Tertipis N.; Gr\u00fcn N.; Romanitan M.; Haeggblom L.; Roosaar A.; Dahll\u00f6f G.; Don\u00e0 M.G.; Benevolo M.; Ramqvist T.; Munck-Wikland E.; Dalianis T.; Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer. Oral Oncol 2014,50(5),491-497","journal-title":"Oral Oncol"},{"key":"ref=140","author":"Max Parkin D.","year":"2009","unstructured":"Max Parkin D.; Bray F.; Ferlay J.; Pisani P.; Global Cancer Statistics, 2002. CA: Cancer J Clin 2009","journal-title":"CA: Cancer J Clin"},{"key":"ref=141","author":"Sobin L.H.","year":"2010","unstructured":"Sobin L.H.; Gospodarowicz M.K.; Wittekind C.; NM Classification of Malignant Tumours 2010","journal-title":"NM Classification of Malignant Tumours"},{"key":"ref=142","unstructured":""},{"key":"ref=143","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/804738","volume":"2014","author":"Cao F.","year":"2014","unstructured":"Cao F.; Han H.; Zhang F.; Wang B.; Ma W.; Wang Y.; HPV infection in esophageal squamous cell carcinoma and its relationship to the prognosis of patients in Northern China. ScientificWorldJournal 2014,2014","journal-title":"ScientificWorldJournal"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2014\/236482","volume":"2014","author":"Liyanage S.S.","year":"2014","unstructured":"Liyanage S.S.; Segelov E.; Malik A.; Garland S.M.; Tabrizi S.N.; Cummins E.; Seale H.; Rahman B.; Moa A.; Barbour A.P.; Crowe P.J.; MacIntyre C.R.; A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in Australia. J Oncol Article ID 2364822014,2014,7","journal-title":"J Oncol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4251\/wjgo.v6.i5.112","volume":"6","author":"Napier K.J.","year":"2014","unstructured":"Napier K.J.; Scheerer M.; Misra S.; Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 2014,6(5),112-120","journal-title":"World J Gastrointest Oncol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/jcp.55.12.885","volume":"55","author":"Syrj\u00e4nen K.J.","year":"2002","unstructured":"Syrj\u00e4nen K.J.; HPV infections and lung cancer. J Clin Pathol 2002,55(12),885-891","journal-title":"J Clin Pathol"},{"key":"ref=147","author":"Kleinberg L.","year":"2014","unstructured":"Kleinberg L.; Kelly R.; Yang S.; Wang J.S.; Forastiere A.A.; Cancer of the esophagus. Abeloff\u2019s Clin Oncol Elsevier 2014","journal-title":"Elsevier"},{"key":"ref=148","author":"Posner M.C.","year":"2015","unstructured":"Posner M.C.; Minsky B.; Ilson D.H.; Cancer of the esophagus. DeVita Hellman Rosenberg\u2019s Cancer Princ. Pract. Oncol. Lippincott- Williams 2015","journal-title":"Lippincott- Williams"},{"key":"ref=149","doi-asserted-by":"publisher","DOI":"10.4178\/epih\/e2015052","volume":"37","author":"Bae J-M.","year":"2015","unstructured":"Bae J-M.; Kim E.H.; Human papillomavirus infection and risk of lung cancer in never-smokers and women: an \u2018adaptive\u2019 meta-analysis. Epidemiol Health 2015,37","journal-title":"Epidemiol Health"},{"key":"ref=150","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/750270","volume":"2012","author":"Prabhu P.R.","year":"2012","unstructured":"Prabhu P.R.; Jayalekshmi D.; Pillai M.R.; Lung cancer and human papilloma viruses (HPVs): Examining the molecular evidence. J. Oncol. J Oncol 2012,2012","journal-title":"J Oncol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/JTO.0b013e3182897c14","volume":"8","author":"van Boerdonk R.A.","year":"2013","unstructured":"van Boerdonk R.A.; Daniels J.M.; Bloemena E.; Krijgsman O.; Steenbergen R.D.; Brakenhoff R.H.; Gr\u00fcnberg K.; Ylstra B.; Meijer C.J.; Smit E.F.; Snijders P.J.; Heideman D.A.; High-risk human papillomavirus-positive lung cancer: Molecular evidence for a pattern of pulmonary metastasis. J Thorac Oncol 2013,8(6),711-718","journal-title":"J Thorac Oncol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/bjc.2015.30","volume":"112","author":"Walter F.M.","year":"2015","unstructured":"Walter F.M.; Rubin G.; Bankhead C.; Morris H.C.; Hall N.; Mills K.; Dobson C.; Rintoul R.C.; Hamilton W.; Emery J.; Symptoms and other factors associated with time to diagnosis and stage of lung cancer: A prospective cohort study. Br J Cancer 2015,112(Suppl. 1),S6-S13","journal-title":"Br J Cancer"},{"key":"ref=153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172760","volume":"12","author":"Islam S.","year":"2017","unstructured":"Islam S.; Dasgupta H.; Roychowdhury A.; Bhattacharya R.; Mukherjee N.; Roy A.; Mandal G.K.; Alam N.; Biswas J.; Mandal S.; Roychoudhury S.; Panda C.K.; Study of association and molecular analysis of human papillomavirus in breast cancer of Indian patients: Clinical and prognostic implication. PLoS One 2017,12(2)","journal-title":"PLoS One"},{"key":"ref=154","first-page":"86","volume":"7","author":"Kolodziej-Andrejuk S.","year":"2013","unstructured":"Kolodziej-Andrejuk S.; Macielag P.; Patyra K.; Mandziuk S.; Pachnia D.; Mazurkiewicz M.; The presence of HPV DNA in breast cancer. J. Pre-Clin. Clin Res 2013,7(2),86-89","journal-title":"Clin Res"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/cancers2020752","volume":"2","author":"Lawson J.S.","year":"2010","unstructured":"Lawson J.S.; Heng B.; Viruses and breast cancer. Cancers (Basel) 2010,2(2),752-772","journal-title":"Cancers (Basel)"},{"key":"ref=156","unstructured":""},{"key":"ref=157","year":"2018","unstructured":"2018"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"Stratton M.R.","year":"2009","unstructured":"Stratton M.R.; Campbell P.J.; Futreal P.A.; The cancer genome. Nature 2009,458(7239),719-724","journal-title":"Nature"},{"key":"ref=159","year":"2019","unstructured":"2019"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.3390\/cancers3033279","volume":"3","author":"Arruebo M.","year":"2011","unstructured":"Arruebo M.; Vilaboa N.; S\u00e1ez-Gutierrez B.; Lambea J.; Tres A.; Valladares M.; Gonz\u00e1lez-Fern\u00e1ndez A.; Assessment of the evolution of cancer treatment therapies. Cancers (Basel) 2011,3(3),3279-3330","journal-title":"Cancers (Basel)"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biochi.2017.08.007","volume":"142","author":"Amani H.","year":"2017","unstructured":"Amani H.; Ajami M.; Nasseri Maleki S.; Pazoki-Toroudi H.; Daglia M.; Tsetegho Sokeng A.J.; Di Lorenzo A.; Nabavi S.F.; Devi K.P.; Nabavi S.M.; Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants. Biochimie 2017,142,63-79","journal-title":"Biochimie"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3390\/ijms18112423","volume":"18","author":"Chan C.W.H.","year":"2017","unstructured":"Chan C.W.H.; Law B.M.H.; So W.K.W.; Chow K.M.; Waye M.M.Y.; Novel strategies on personalized medicine for breast cancer treatment: An update. Int J Mol Sci 2017,18(11),2423","journal-title":"Int J Mol Sci"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"10239","DOI":"10.1021\/acs.analchem.7b01582","volume":"89","author":"Yang F.","year":"2017","unstructured":"Yang F.; Zhang T-T.; Li S-S.; Song P.; Zhang K.; Guan Q-Y.; Kang B.; Xu J.J.; Chen H.Y.; Endogenous microRNA-triggered and real-time monitored drug release via cascaded energy transfer payloads. Anal Chem 2017,89(19),10239-10247","journal-title":"Anal Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.oraloncology.2015.11.022","volume":"56","author":"Geiger J.L.","year":"2016","unstructured":"Geiger J.L.; Grandis J.R.; Bauman J.E.; The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations. Oral Oncol 2016,56,84-92","journal-title":"Oral Oncol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/s41598-019-42633-9","volume":"9","author":"Amani H.","year":"2019","unstructured":"Amani H.; Habibey R.; Shokri F.; Hajmiresmail S.J.; Akhavan O.; Mashaghi A.; Pazoki-Toroudi H.; Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling. Sci Rep 2019,9(1),6044","journal-title":"Sci Rep"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.2147\/IJN.S105173","volume":"11","author":"Hassan C.E.","year":"2016","unstructured":"Hassan C.E.; Webster T.J.; The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth. Int J Nanomedicine 2016,11,3641-3654","journal-title":"Int J Nanomedicine"},{"key":"ref=167","unstructured":""},{"key":"ref=168","volume":"12","author":"Chen Z.","year":"2017","unstructured":"Chen Z.; Jing Y.; Wen Q.; Ding X.; Wang T.; Mu X.; Chenzhang Y.; Cao M.; E6 and E7 gene polymorphisms in human papillomavirus types-58 and 33 identified in Southwest China. PLoS One 2017,12(1)","journal-title":"PLoS One"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virol.2017.05.005","volume":"508","author":"Harden M.E.","year":"2017","unstructured":"Harden M.E.; Munger K.; Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles. Virology 2017,508,63-69","journal-title":"Virology"},{"key":"ref=170","author":"Cindy C.","year":"2017","unstructured":"Cindy C.; Eva-Katharina P.; Jennifer B.; Katharina F.F.; Melissa M.; Elizabeth A.W.; Karl M.; Peter M.H.; Craig M.; Michaela U.G.; The human papillomavirus E6 oncoprotein targets USP15 and TRIM25 to suppress RIG-I-mediated innate immune signaling. J Virol 2017","journal-title":"J Virol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:52:26Z","timestamp":1610758346000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174055\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":170,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,11,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201020666190802115722","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}